SREBP-1c regulates the synthesis of fatty acids and triglycerides, and its downregulation by FXR activation helps prevent excessive lipid accumulation in the liver, promoting the clearance of VLDL and reducing the risk of fatty liver disease [22]. This evidence concerns the gene SREBF1 and fatty liver disease.